ArticleBMC medicine2023

CAR-T cells targeting CD38 and LMP1 exhibit robust antitumour activity against NK/T cell lymphoma.

Hongwen Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.